November 8, 2024
Moderna’s mRNA RSV Vaccine Receives Health Canada Approval For Adults Aged 60 Years And Over
November 1, 2024
Completion of Moderna’s Vaccine Production Line at Novocol Pharma Enhances Ontario’s Biomanufacturing Strength
No current content.